Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/207946
Title: Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines
Author: Cavestro, Giulia Martina
Mannucci, Alessandro
Balaguer, Francesc
Hampel, Heather
Kupfer, Sonia S.
Repici, Alessandro
Sartore-Bianchi, Andrea
Seppala, Toni T.
Valentini, Vincenzo
Boland, Clement Richard
Brand, Randall E.
Buffart, Tineke E.
Burke, Carol A.
Caccialanza, Riccardo
Cannizzaro, Renato
Cascinu, Stefano
Cercek, Andrea
Crosbie, Emma J.
Danese, Silvio
Dekker, Evelien
Daca-Alvarez Maria
Deni, Francesco
Dominguez Valentin, Mev
Eng, Cathy
Goel, Ajay
Guillem, Jose G.
Houwen, Britt B. S. L.
Kahi, Charles
Kalady, Matthew F.
Kastrinos, Fay
Kuehn, Florian
Laghi, Luigi
Latchford, Andrew
Liska, David
Lynch, Patrick M.
Malesci, Alberto
Mauri, Giancarlo
Meldolesi, Elisa
Moller, Pal
Monahan, Kevin
Moeslein, Gabriela
Murphy, Caitlin J.
Nass, Karlijn
Ng, Kimmie
Oliani, Cristina
Papaleo, Enrico
Patel, Swati G.
Puzzono, Marta
Remo, Andrea
Ricciardiello, Luigi
Ripamonti, Carla Ida
Siena, Salvatore
Singh, Satish K.
Stadler, Zsofia K.
Stanich, Peter P.
Syngal, Sapna
Turi, Stefano
Urso, Emanuele Damiano
Valle, Laura
Vanni, Valeria Stella
Vilar, Eduardo
Vitellaro, Marco
You, Yi-Qian Nancy
Yurgelun, Matthew B.
Zuppardo, Raffaella Alessia
Stoffel, Elena
Keywords: Diagnòstic
Càncer colorectal
Adults
Diagnosis
Colorectal cancer
Adulthood
Issue Date: 20-Dec-2022
Publisher: Elsevier
Abstract: Background & aims: Patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), composed of 69 experts, was convened to develop the first evidence-based consensus recommendations for eoCRC. Methods: After reviewing the published literature, a Delphi methodology was used to draft and respond to clinically relevant questions. Each statement underwent 3 rounds of voting and reached a consensus level of agreement of ≥80%. Results: The DIRECt group produced 31 statements in 7 areas of interest: diagnosis, risk factors, genetics, pathology-oncology, endoscopy, therapy, and supportive care. There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment. All newly diagnosed eoCRC patients should receive germline genetic testing, ideally before surgery. On the basis of current evidence, endoscopic, surgical, and oncologic treatment of eoCRC should not differ from later-onset CRC, except for individuals with pathogenic or likely pathogenic germline variants. The evidence on chemotherapy is not sufficient to recommend changes to established therapeutic protocols. Fertility preservation and sexual health are important to address in eoCRC survivors. The DIRECt group highlighted areas with knowledge gaps that should be prioritized in future research efforts, including age at first screening for the general population, use of fecal immunochemical tests, chemotherapy, endoscopic therapy, and post-treatment surveillance for eoCRC patients. Conclusions: The DIRECt group produced the first consensus recommendations on eoCRC. All statements should be considered together with the accompanying comments and literature reviews. We highlighted areas where research should be prioritized. These guidelines represent a useful tool for clinicians caring for patients with eoCRC.
Note: Reproducció del document publicat a: https://doi.org/10.1016/j.cgh.2022.12.006
It is part of: Clinical Gastroenterology and Hepatology, 2022, vol. 21, num.3, p. 581-637
URI: https://hdl.handle.net/2445/207946
Related resource: https://doi.org/10.1016/j.cgh.2022.12.006
ISSN: 1542-3565
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
257049.pdf2.32 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons